Back to search

Gylden Pharma Limited

09955881

active
Private Limited Company
Companies House
Health Score
76 / 100

Some Concerns

30/30
Filing
10/30
Financial
36/40
Risk
  • Negative net worth (-10)
  • 2 outstanding charges (-4)

Details

4 & 5 DUNMORE COURT, ABINGDON, OX13 6BH
Incorporated 18/01/2016

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Ms Storme Jo-Anne Moore-Thornicroft

director · Since 18/01/2016

DIRECTOR

BRITISH · UNITED KINGDOM · Age 52

Also on 4 other boards

Professor Thomas William Rademacher

director · Since 18/01/2016

DIRECTOR

AMERICAN · ENGLAND · Age 76

Also on 6 other boards

Dr Finian Tan Seng Chin

director · Since 03/09/2019

ENTREPRENEUR

SINGAPOREAN · SINGAPORE · Age 64

Mr David Clifford Jackson

director · Since 17/08/2022

COMPANY DIRECTOR

BRITISH · ENGLAND · Age 77

Also on 3 other boards

Mr Frank Tufaro

director · Since 17/08/2022

COMPANY DIRECTOR

AMERICAN · UNITED STATES · Age 71

Dr Ricardo De Godoi Mattos Ferreira

director · Since 27/09/2023

BIOLOGIST, RESEARCHER

BRAZILIAN · BRAZIL · Age 46

Dr Poh Hui Chia

director · Since 05/01/2024

ASSOCIATE DIRECTOR

SINGAPOREAN · SINGAPORE · Age 43

Persons with Significant Control

Professor Thomas William Rademacher

Significant control

American · England · Age 76

4 & 5 Dunmore Court, Wootton Road, Abingdon, OX13 6BH

Notified 06/04/2016

Charges2 outstanding

Charge
outstanding

VICKERS VENTURE FUND VI PTE. LTD. AS SECURITY TRUSTEE FOR EACH OF THE SECURED PARTIES

Created 07/11/2025Registered 26/11/2025
Charge
outstanding

VICKERS VENTURE FUND VI PTE. LTD. AS SECURITY TRUSTEE

Created 10/09/2025Registered 30/09/2025
Charge
satisfied

IMMUNOTOPE, INC.

Created 23/02/2017Registered 06/03/2017Satisfied 03/05/2022

CompanyRankvs 1937+ SIC 72110 peers
33

Financial strength2th percentile among SIC peers · 1/25
Employees98th percentile among SIC peers · 15/15
LiquidityCurrent ratio 0.15× · 2/20
Longevity10 years trading (max 15) · 10/15
Filing complianceAll filings up to date · 15/15
Outstanding charges -10
Show leaderboard
How is this score calculated?
Financial strength1/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity10/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/03/2025

Net Worth

-£3.3M

Balance sheet strength

Cash

£294k

Cash in the bank

Net Current Assets

-£3.5M

Working capital

Current Assets

£611k

Current Liabilities

£4.1M

Fixed Assets

£1.3M

Debtors

£317k

36avg. employees-3

Balance Sheet

Intangible assets£620k
Assets less current liabilities-£2.2M
Signed by 2024-04-01Prepared with Companies House

EstimatesDerived

YearCurrent RatioImplied Profit
20250.15-£5.1M
20240.54

Derived from filed accounts. Not audited figures.